微生物のリズム追跡により代謝疾患治療の新たな標的が明らかに(Tracking Microbial Rhythms Reveals New Target for Treating Metabolic Diseases)

ad

2025-06-18 カリフォルニア大学サンディエゴ校(UCSD)

カリフォルニア大学サンディエゴ校の研究で、腸内微生物の24時間周期リズムが代謝疾患の新たな治療標的となる可能性が示された。時間制限食事により腸内環境のリズムが整い、脂肪や糖の代謝が改善。微生物が発する代謝シグナルがエネルギー消費やインスリン感受性に影響を与えることが判明した。今後、食事タイミングと内容を腸内リズムに基づき調整することで、肥満や糖尿病の治療に応用可能な新戦略として期待されている。

<関連情報>

メタトランスクリプトミクスにより、代謝に重大な影響を及ぼす細菌導入遺伝子の日内機能シフトが発見される Metatranscriptomics uncovers diurnal functional shifts in bacterial transgenes with profound metabolic effects

Stephany Flores Ramos ∙ Nicole Siguenza ∙ Wuling Zhong ∙ … ∙ Satchidananda Panda ∙ Rob Knight ∙ Amir Zarrinpar
Cell Host & Microbe  Published:June 18, 2025
DOI:https://doi.org/10.1016/j.chom.2025.05.024

Graphical abstract

微生物のリズム追跡により代謝疾患治療の新たな標的が明らかに(Tracking Microbial Rhythms Reveals New Target for Treating Metabolic Diseases)

Highlights

  • Metatranscriptomics reveals diurnal functional shifts missed by metagenomics
  • Time-restricted feeding (TRF) restores microbial transcript cycling under high-fat diet
  • D. newyorkensis bsh1 (DnBSH1) exhibits unique diurnal expression under TRF conditions
  • Administration of E. coli engineered to express DnBSH1 improves mouse metabolic health

Summary

Diurnal rhythmicity in the gut maintains gut integrity, circadian rhythms, and metabolic homeostasis. However, existing studies focus on microbial composition rather than transcriptional activity. To understand microbial functional dynamics, we characterize diurnal fluctuations in the mouse cecal metatranscriptome and metagenome under high-fat diet and time-restricted feeding (TRF). We show that metatranscriptomics uncovers TRF-induced time-dependent microbial functional shifts that are undetectable with metagenomics alone. We also found bile salt hydrolase (bsh) from Dubosiella newyorkensis exhibits diurnal expression in the TRF group. Engineering this bsh, along with other candidates, into a native E. coli chassis reveals distinct differences in deconjugation and amidation activities, underscoring functional specificity. In vivo, a D. newyorkensis bsh improves insulin sensitivity, glucose tolerance, and body composition, suggesting a direct role in TRF metabolic benefits. This study highlights how coupling metatranscriptomics with engineered bacterial systems is a powerful approach for uncovering time-dependent bacterial functions related to health and disease.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました